Synairgen plc announced the appointment of Theodora Harold as an independent Non-Executive Director of the Company and Chair of the Audit Committee with immediate effect. Theodora has over 20 years’ experience in the biotech sector and is currently CEO of Crescendo Biologics Ltd. She was previously part of the founding management teams of both PsiOxus Therapeutics Ltd. and Mission Therapeutics Ltd. Theodora has previous non-executive director experience at Chronos Therapeutics Ltd. Theodora is also a Chartered Accountant having qualified at PricewaterhouseCoopers.